The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart. (2019)
Attributed to:
Developing chemical mass spectrometry probes to assess the production of reactive oxygen species in vivo
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10557-019-06914-9
PubMed Identifier: 31654171
Publication URI: http://europepmc.org/abstract/MED/31654171
Type: Journal Article/Review
Volume: 33
Parent Publication: Cardiovascular drugs and therapy
Issue: 6
ISSN: 0920-3206